These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nonbarrier contraceptives and vaginitis and vaginosis. Roy S Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1240-4. PubMed ID: 1951581 [TBL] [Abstract][Full Text] [Related]
3. Relationship between contraceptive method and vaginal flora. Peddie BA; Bishop V; Bailey RR; McGill H Aust N Z J Obstet Gynaecol; 1984 Aug; 24(3):217-8. PubMed ID: 6596089 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of Candida vulvovaginitis. Sobel JD Curr Top Med Mycol; 1989; 3():86-108. PubMed ID: 2688924 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Sobel JD Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 2):924-35. PubMed ID: 3895958 [TBL] [Abstract][Full Text] [Related]
9. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle. Nelson AL Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201 [TBL] [Abstract][Full Text] [Related]
10. [Oral and vaginal Candida colonization under the influence of hormonal contraception (author's transl)]. Klinger G; Tiller FW; Klinger G Zahn Mund Kieferheilkd Zentralbl; 1982; 70(2):120-5. PubMed ID: 6211864 [TBL] [Abstract][Full Text] [Related]
11. Influence of oral contraceptives on the presence and persistence of Candida albicans and beta-haemolytic streptococci in the vagina. Morris CA J Clin Pathol; 1969 Jul; 22(4):488-91. PubMed ID: 5798639 [TBL] [Abstract][Full Text] [Related]
13. [Effect of hormonal contraceptives on the incidence of mycotic vulvovaginitis]. Sitek T; Merkel M; Pisarek-Miedzińska D Ginekol Pol; 1984 Sep; 55(9):669-73. PubMed ID: 6534812 [No Abstract] [Full Text] [Related]
14. Vaginal moniliasis in private practice. Davis BA Obstet Gynecol; 1969 Jul; 34(1):40-5. PubMed ID: 5791314 [No Abstract] [Full Text] [Related]
15. Candidial vaginitis associated with the use of oral progestational agents. Walsh H; Hildebrandt RJ; Prystowsky H Am J Obstet Gynecol; 1965 Nov; 93(6):904-5. PubMed ID: 5845223 [TBL] [Abstract][Full Text] [Related]
16. Candida vaginitis during contraceptive use: the influence of methods, antifungal susceptibility and virulence patterns. Güzel AB; Küçükgöz-Güleç U; Aydin M; Gümral R; Kalkanci A; Ilkit M J Obstet Gynaecol; 2013 Nov; 33(8):850-6. PubMed ID: 24219728 [TBL] [Abstract][Full Text] [Related]
17. General yeast infection in Bangladeshi women using contraceptives. Rahman KM; Chowdhury TA; Nahar N; Huq JA Bangladesh Med Res Counc Bull; 1984 Dec; 10(2):65-70. PubMed ID: 6532412 [TBL] [Abstract][Full Text] [Related]
18. On the epidemiology of oral contraceptives and disease. Prentice RL; Thomas DB Adv Cancer Res; 1987; 49():285-401. PubMed ID: 3314396 [TBL] [Abstract][Full Text] [Related]